Advanced breast cancer medicine now available in Slovenia
Ljubljana, 14 June - Alpelizib, the only targeted therapy for a specific type of advanced breast cancer, is now accessible to patients in Slovenia, making it one of the few countries where it is available. The Institute of Oncology already started treating patients in the compassionate use programme before the drug was registered.
The rest of this news item is available to subscribers.
The news item consists of 1.153 characters (without spaces) or 204 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.